FTX’s new leadership has requested federal bankruptcy judge approval to begin selling off four of its businesses including LedgerX, by the early months of 2023.
The U.S. Food and Drug Administration (FDA) has granted PharmaTher Holdings Ltd. (OTCQB: PHRRF) an Orphan Drug designation for ketamine in the prevention of injury from organ transplantation.